SCHEMBL1556619

SCHEMBL1556619

CC1=C(C2=CC(=O)c3ccccc3C2=O)C(=O)c2cccc(C)c2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 4/20 0.46
▸ CDC25B P30305 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ CYP3A4 P08684 3/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ HBB P68871 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ IDO1 P14902 2/20 0.45
▸ CDC25A P30304 2/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ PLIN1 O60240 1/20 0.45
▸ NR1I2 O75469 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ GSR P00390 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29424584 0.86 BACE1 (0.56) BACE1CDC25BALDH1A1CYP3A4MAPK1
SCHEMBL30580334 0.73 ALDH1A1 (0.66) CDC25BALDH1A1CYP3A4MAPK1HBB
SCHEMBL224650 0.73 ALDH1A1 (0.66) CDC25BALDH1A1CYP3A4MAPK1HBB
SCHEMBL2265203 0.73 CA1 (0.47) CDC25BALDH1A1CYP3A4MAPK1HBB
SCHEMBL22411120 0.71 MAPT (0.53) BACE1CDC25BALDH1A1CYP3A4MAPK1
SCHEMBL1688847 0.71 ALDH1A1 (0.55) ALDH1A1CYP3A4MAPK1HBBSMN1; SMN2
SCHEMBL6555840 0.71 BACE1 (0.75) BACE1CDC25BALDH1A1CYP3A4MAPK1
SCHEMBL3976848 0.69 SMN1; SMN2 (0.55) CDC25BALDH1A1CYP3A4MAPK1HBB
SCHEMBL29392682 0.69 ALDH1A1 (0.60) CDC25BALDH1A1CYP3A4MAPK1HBB
SCHEMBL14852073 0.69 PTPRC (0.63) CDC25BALDH1A1CYP3A4MAPK1HBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011044375-A2 APOGOSSYPOLONE DERIVATIVES AS ANTICANCER AGENTS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2011-04-14 — — WO disclosed
Send feedback